CRISPR-based genome editing has considerable therapeutic potential in a wide range of diseases 1,2,3,4,5. A key challenge is achieving efficient, clinically suitable delivery of genome editing ...
An emerging body of evidence indicates that post-transcriptional gene regulation relies not only on the sequence of mRNAs but also on their folding into intricate secondary structures and on the ...